Targacept, Inc. Reports First Quarter 2011 Financial Results

Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today reported its financial results for the first quarter ended March 31, 2011.
MORE ON THIS TOPIC